The high dose employed is likely to reach a concentration that is near or greater than the dissociation constant of of IFN-γ for its cognate receptor (Littman et al., 1985) but is lower than used in previous models of PD (Castaño et al., 2002; Chien et al., 2016). Here, IFNG is linked to Parkinson disease.